Asciminib Pediatric formulation group Clinical Trials

1 actively recruiting trial across 1 location

Also known as: ABL001

Filter by location:

Indianapolis, Indiana1 trial

Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

Indiana UH Riley H for CIU

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.